A Study to Assess Safety and Tolerabiltiy Associated With a Switch From Oral Antipsychotic Medications to Long-acting Injectable Risperidone in Patients With Schizophrenia.
Clinical trial NCT00034775 · COMPLETED
Trial details
- NCT number
- NCT00034775
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2001-08-01
- Enrollment
- 141
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.